GECCO
Great Elm Capital Corp.
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
Jun 8, 2026
SEC
Great Elm Capital Corp. amended its credit agreement with City National Bank, extending the revolving facility maturity
8-K — Impact 3/10
May 27, 2026
SEC
Nasdaq filed a Form 25-NSE to remove from listing and registration Great Elm Capital Corp.'s 5.875% Notes due 2026, effe
25-NSE — Impact 2/10
Apr 27, 2026
SEC
Great Elm Capital Corp. is redeeming all of its outstanding 5.875% Notes due 2026 (GECCO) on May 27, 2026 at 100% of pri
8-K — Impact 3/10
Analyst Ratings
2Strong Buy
4Buy
3Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
3/10
Great Elm Capital Corp. amended its credit agreement with City National Bank, extending the revolving facility maturity
Jun 8, 2026
NEUTRAL
25-NSE
2/10
Nasdaq filed a Form 25-NSE to remove from listing and registration Great Elm Capital Corp.'s 5.875% Notes due 2026, effe
May 27, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 2.7/10.
NEUTRAL
8-K
3/10
Great Elm Capital Corp. amended its credit agreement with City National Bank, extending the revolvin
Jun 8, 2026
NEUTRAL
25-NSE
2/10
Nasdaq filed a Form 25-NSE to remove from listing and registration Great Elm Capital Corp.'s 5.875%
May 27, 2026
NEUTRAL
8-K
3/10
Great Elm Capital Corp. is redeeming all of its outstanding 5.875% Notes due 2026 (GECCO) on May 27,
Apr 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 67% buy across 9 analysts — 2 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| May 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Apr 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Mar 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Feb 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Jan 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.